Nanoliposomal Irinotecan clinical trials

Explore recruiting nanoliposomal irinotecan clinical trials.

Recruiting nanoliposomal irinotecan studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Nanoliposomal Irinotecan trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and safety of trifluridin/tipiracil in combination with nanoliposomal irinotecan as a second line therapy in patients with cholangiocarcinoma

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis from Gastrointestinal cancer: a phase I study.

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

Nanoliposomal Irinotecan trials by city

Nanoliposomal Irinotecan in Toronto Nanoliposomal Irinotecan in Vancouver Nanoliposomal Irinotecan in Montreal Nanoliposomal Irinotecan in Calgary Nanoliposomal Irinotecan in Edmonton Nanoliposomal Irinotecan in Ottawa Nanoliposomal Irinotecan in Winnipeg Nanoliposomal Irinotecan in Quebec City Nanoliposomal Irinotecan in Hamilton Nanoliposomal Irinotecan in Kitchener Nanoliposomal Irinotecan in London Nanoliposomal Irinotecan in Halifax Nanoliposomal Irinotecan in New York Nanoliposomal Irinotecan in Los Angeles Nanoliposomal Irinotecan in Chicago Nanoliposomal Irinotecan in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease